Press Releases Highlights

October 07 - October 11, 2024

$AMPG AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a company that designs, develops, and manufactures cutting-edge signal processing components for satellite, Public and Private 5G, and other communication networks, as well as complete 5G/6G systems. They are also a global distributor of packages and lids for integrated circuit assembly. Today, it is announced that the United States Patent and Trademark Office (USPTO) has granted AmpliTech Group a Notice of Allowance for their patent application regarding their innovative 5G Technology and a patent for their cryogenic solution for Quantum Computing Applications. The formal patent certificates are expected to be issued within 30 – 45 days.

$SKYX SKYX Platforms Corp. (NASDAQ: SKYX), a global leader in smart platform technology with over 97 issued and pending patents and more than 60 websites dedicated to lighting and home decor. Today, the company announced a strategic investment of $11 million in a new class of preferred stock with a conversion price of $2.00 per common share, offering an 8% annual dividend. This investment round was spearheaded by Lance Shaner, the Chairman & CEO of Shaner Hotel Group, and included other strategic partners and key investors in SKYX.

$SOTK Sono-Tek Corporation (NASDAQ: SOTK), a prominent developer and producer of ultrasonic coating systems, has announced that it will host a conference call to review its financial performance for the fiscal second quarter and the first half of 2025, which ended on August 31, 2024. The call is scheduled for Tuesday, October 15, 2024, at 10:00 am ET

$OCX Oncocyte Corp. (Nasdaq: OCX) recently announced the publication of favorable results regarding its unique gene expression test known as DetermaIO™. These results were featured in the peer-reviewed journal Clinical Cancer Research. The study confirmed the effectiveness of DetermaIO in pinpointing breast cancer patients who are most likely to respond positively to atezolizumab treatment. This innovative test is designed to cater to a lucrative market within the field of oncology diagnostics, representing a significant opportunity for the company

$SKYX (NASDAQ: SKYX), operating under the name "SKYX Technologies," is a cutting-edge technology company focused on smart platform solutions. With a robust portfolio of over 97 patents in the United States and worldwide, the company manages a network of more than 60 websites specializing in lighting and home decoration. Committed to elevating the standards of smart, secure, and advanced living spaces, SKYX Technologies has recently shared a corporate update highlighting substantial insider purchases.

$LIPO Lipella Pharmaceuticals, Inc. (Nasdaq: LIPO) ("Lipella"), a biotech company in the clinical development stage that focuses on treating severe illnesses with significant unmet medical needs, has announced that its CEO, Jonathan Kaufman, PhD, is scheduled to speak at the Maxim Healthcare Virtual Summit 2024, taking place from October 15 to 17, 2024

About PRISM MediaWire:

PRISM MediaWire provides access to leading financial and trade media outlets, along with key trading platforms. This positions companies at the center of financial market dialogues and trends, providing significant visibility in the competitive capital markets. PRISM MediaWire’s distribution service is further augmented by:

  • 24/7 Support: Clients benefit from round-the-clock access to PRISM MediaWire's dedicated support team, ensuring timely assistance is always available.

  • Competitive Pricing: PRISM MediaWire offers its top-tier newswire distribution services at competitive rates, providing value for its clients.

  • Unlimited Word Count: There are no restrictions on the length of press releases, allowing clients the flexibility to convey their messages comprehensively without word count limitations.

  • No Extra Fee for Embedded Images and Videos: PRISM MediaWire enables clients to augment their press releases with images and videos, enhancing their content's visual appeal and engagement without incurring additional costs.

Visit our website, prismmediawire.com, and follow us on X.

Contact:

(646) 863-7997

Reply

or to participate.